Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07600671
Eating Disorder Dynamic InterventionNational Institutes of Health (NIH)Not Yet RecruitingNot Applicable
NCT07600671Not Yet Recruiting
Not Applicable
Eating Disorder Dynamic InterventionNational Institutes of He...
NCT07603375
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal AdenocarcinomaDuke UniversityNot Yet RecruitingPhase 2
NCT07603375Not Yet Recruiting
Phase 2
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Lo...Duke University
NCT07603895
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal CandidiasisBioithas SLRecruitingNot Applicable
NCT07603895Recruiting
Not Applicable
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for V...Bioithas SL
NCT07602179
Analgesic Efficacy and Hemodynamic Stability of Ultrasound-guided Thoracic Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in Pediatric Thoracic Surgery: a Randomized Controlled Trial.Nguyen Dang ThuCompletedNot Applicable
NCT07602179Completed
Not Applicable
Analgesic Efficacy and Hemodynamic Stability of Ultrasound-guided Thoracic Erect...Nguyen Dang Thu
NCT07605182
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal AgeAndrology and Fertility Hospital of HanoiNot Yet RecruitingNot Applicable
NCT07605182Not Yet Recruiting
Not Applicable
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Pa...Andrology and Fertility H...
NCT07603128
Multicenter Validation of a Risk Prediction Model for MDRGNB InfectionRuijin HospitalNot Yet Recruiting
NCT07603128Not Yet Recruiting
—
Multicenter Validation of a Risk Prediction Model for MDRGNB InfectionRuijin Hospital
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07604272
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesNorthwestern UniversityNot Yet RecruitingPhase 1
NCT07604272Not Yet Recruiting
Phase 1
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Ingui...Northwestern University
NCT07603986
CBT for Anger and Aggression in Children: a Pilot Study of Irritability and SuicidalityChief Scientist, The Israel Ministry of ScienceCompletedNot Applicable
NCT07603986Completed
Not Applicable
CBT for Anger and Aggression in Children: a Pilot Study of Irritability and Suic...Chief Scientist, The Isra...
NCT07601711
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySichuan Provincial People's HospitalRecruiting
NCT07601711Recruiting
—
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySichuan Provincial People...
NCT07603037
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureFirst Affiliated Hospital of Wannan Medical CollegeNot Yet RecruitingNot Applicable
NCT07603037Not Yet Recruiting
Not Applicable
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion...First Affiliated Hospital...
NCT07601269
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.RecruitingEarly Phase 1
NCT07601269Recruiting
Early Phase 1
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.
NCT07605312
AI-Based Risk Prediction Model for Upper Digestive Tract CancerNational Taiwan University HospitalNot Yet Recruiting
NCT07605312Not Yet Recruiting
—
AI-Based Risk Prediction Model for Upper Digestive Tract CancerNational Taiwan Universit...
NCT07602647
Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia RepairFudan UniversityNot Yet Recruiting
NCT07602647Not Yet Recruiting
—
Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Unde...Fudan University
NCT07603219
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Family - N4F)Medical University of GdanskNot Yet RecruitingNot Applicable
NCT07603219Not Yet Recruiting
Not Applicable
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Fa...Medical University of Gda...
NCT07604142
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant PlacementTanta UniversityEnrolling By InvitationNot Applicable
NCT07604142Enrolling By Invitation
Not Applicable
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant...Tanta University
NCT07601490
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyNot Yet RecruitingNot Applicable
NCT07601490Not Yet Recruiting
Not Applicable
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Tra...
NCT07604766
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaGenmabNot Yet RecruitingPhase 3
NCT07604766Not Yet Recruiting
Phase 3
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Inv...Genmab
NCT07601113
PG2 Breast Cancer Evaluation in Adjuvant Medicine-Survival StudyKun-Ming RauNot Yet Recruiting
NCT07601113Not Yet Recruiting
—
PG2 Breast Cancer Evaluation in Adjuvant Medicine-Survival StudyKun-Ming Rau
NCT07604558
A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07604558Not Yet Recruiting
Phase 1
A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injectio...AbbVie
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 12 (10%)
Early Phase 11 (5%)
Phase 31 (5%)